These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 17175290)
1. Desensitized renal transplant recipients show reduced cellular responses to in vitro challenge. Kimball P; King A Transplant Proc; 2006 Dec; 38(10):3416-7. PubMed ID: 17175290 [TBL] [Abstract][Full Text] [Related]
2. Intravenous immune globulin treatment inhibits crossmatch positivity and allows for successful transplantation of incompatible organs in living-donor and cadaver recipients. Jordan SC; Vo A; Bunnapradist S; Toyoda M; Peng A; Puliyanda D; Kamil E; Tyan D Transplantation; 2003 Aug; 76(4):631-6. PubMed ID: 12973100 [TBL] [Abstract][Full Text] [Related]
3. Kinetics of cellular and humoral immunity in a successful case of positive crossmatch kidney transplantation: a case report. Tanimine N; Ide K; Yamashita M; Tanaka Y; Igarashi Y; Banshodani M; Tazawa H; Basnet NB; Doskali M; Onoe T; Tashiro H; Ohdan H Transplant Proc; 2011; 43(6):2411-4. PubMed ID: 21839279 [TBL] [Abstract][Full Text] [Related]
6. Living donor kidney transplantation across positive crossmatch: the University of Illinois at Chicago experience. Thielke JJ; West-Thielke PM; Herren HL; Bareato U; Ommert T; Vidanovic V; Campbell-Lee SA; Tzvetanov IG; Sankary HN; Kaplan B; Benedetti E; Oberholzer J Transplantation; 2009 Jan; 87(2):268-73. PubMed ID: 19155983 [TBL] [Abstract][Full Text] [Related]
7. Perioperative Desensitization Improves Outcomes Among Crossmatch Positive Recipients of Deceased Donor Renal Transplants. Sharma A; King A; Kumar D; Behnke M; McDougan F; Kimball PM Prog Transplant; 2016 Jun; 26(2):157-61. PubMed ID: 27207404 [TBL] [Abstract][Full Text] [Related]
8. Renal transplantation in patients with positive lymphocytotoxicity crossmatches: one center's experience. Magee CC; Felgueiras J; Tinckam K; Malek S; Mah H; Tullius S Transplantation; 2008 Jul; 86(1):96-103. PubMed ID: 18622284 [TBL] [Abstract][Full Text] [Related]
9. Intravenous immunoglobulin, HLA allele typing and HLAMatchmaker facilitate successful transplantation in highly sensitized pediatric renal allograft recipients. Valentini RP; Nehlsen-Cannarella SL; Gruber SA; Mattoo TK; West MS; Lang C; Imam AA Pediatr Transplant; 2007 Feb; 11(1):77-81. PubMed ID: 17239127 [TBL] [Abstract][Full Text] [Related]
10. [Desensitization protocols in immunized living donor kidney transplant recipients]. Nocera A G Ital Nefrol; 2009; 26(4):499-515. PubMed ID: 19644839 [TBL] [Abstract][Full Text] [Related]
11. Hyperimmunized patients awaiting cadaveric kidney graft: is there a quick desensitization possible? Faenza A; Fuga G; Bertelli R; Scolari MP; Buscaroli A; Stefoni S Transplant Proc; 2008; 40(6):1833-8. PubMed ID: 18675064 [TBL] [Abstract][Full Text] [Related]
12. Acceptable donor-specific antibody levels allowing for successful deceased and living donor kidney transplantation after desensitization therapy. Reinsmoen NL; Lai CH; Vo A; Cao K; Ong G; Naim M; Wang Q; Jordan SC Transplantation; 2008 Sep; 86(6):820-5. PubMed ID: 18813107 [TBL] [Abstract][Full Text] [Related]
13. Highly successful living donor kidney transplantation after conversion to negative of a previously positive flow-cytometry cross-match by pretransplant plasmapheresis. Thielke J; DeChristopher PJ; Sankary H; Oberholzer J; Testa G; Benedetti E Transplant Proc; 2005 Mar; 37(2):643-4. PubMed ID: 15848486 [TBL] [Abstract][Full Text] [Related]
14. Efficacy, outcomes, and cost-effectiveness of desensitization using IVIG and rituximab. Vo AA; Petrozzino J; Yeung K; Sinha A; Kahwaji J; Peng A; Villicana R; Mackowiak J; Jordan SC Transplantation; 2013 Mar; 95(6):852-8. PubMed ID: 23511212 [TBL] [Abstract][Full Text] [Related]
15. Using donor exchange paradigms with desensitization to enhance transplant rates among highly sensitized patients. Montgomery RA; Lonze BE; Jackson AM Curr Opin Organ Transplant; 2011 Aug; 16(4):439-43. PubMed ID: 21666478 [TBL] [Abstract][Full Text] [Related]
16. Proposed relationship between intravenous immunoglobulin and thrombosis in renal transplant recipients. Duronio A; Bajjoka I; Hsaiky L; Parasuraman R Ann Pharmacother; 2007 Feb; 41(2):354-8. PubMed ID: 17264157 [TBL] [Abstract][Full Text] [Related]
17. Management of sensitized patients awaiting renal transplantation: does sequential therapy of intravenous immunoglobulin and simvastatin offer a solution? Mahmoud KM; Sobh MA; El Shenawy F; Isamil AM; El-Magd MA; Hassan NA; El-Agroudy AE; Sheashaa HA; Opelz G; Ghoneim MA Eur J Pharmacol; 2007 Apr; 561(1-3):202-5. PubMed ID: 17296177 [TBL] [Abstract][Full Text] [Related]
18. Successful treatment of chronic antibody-mediated rejection with IVIG and rituximab in pediatric renal transplant recipients. Billing H; Rieger S; Ovens J; Süsal C; Melk A; Waldherr R; Opelz G; Tönshoff B Transplantation; 2008 Nov; 86(9):1214-21. PubMed ID: 19005402 [TBL] [Abstract][Full Text] [Related]
19. Use of high-dose human intravenous immunoglobulin therapy in sensitized patients awaiting transplantation: the Cedars-Sinai experience. Jordan SC; Vo AA; Nast CC; Tyan D Clin Transpl; 2003; ():193-8. PubMed ID: 15387111 [TBL] [Abstract][Full Text] [Related]